Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 21:2021:736-743.
eCollection 2021.

Testing of a Risk-Standardized Major Bleeding and Venous Thromboembolism Electronic Clinical Quality Measure for Elective Total Hip and/or Knee Arthroplasties

Troy Li  1 , Mica Curtin-Bowen  1 , Avery Pullman  1 , Stuart Lipsitz  1   2 , Ania Syrowatka  1 , Michael Sainlaire  1 , Tien Thai  1 , Alexandra Businger  1 , Aileen Davis  3 , Jay R Lieberman  4 , Bonnie Blanchfield  1   5 , David W Bates  1   2 , Patricia C Dykes  1   2
Affiliations

Testing of a Risk-Standardized Major Bleeding and Venous Thromboembolism Electronic Clinical Quality Measure for Elective Total Hip and/or Knee Arthroplasties

Troy Li et al. AMIA Annu Symp Proc. .

Abstract

Brigham and Women's Hospital has received funding from the Centers for Medicare and Medicaid Services to develop a novel electronic clinical quality measure to assess the risk-standardized major bleeding and venous thromboembolism (VTE) rate following elective total hip and/or knee arthroplasty. There are currently no existing measures that evaluate both the bleeding and VTE events following joint arthroplasty (TJA). Our novel composite measure was tested within two academic health systems with 17 clinician groups meeting the inclusion criteria. Following risk adjustment, the overall adjusted bleeding rate was 3.87% and ranged between 1.99% - 5.66%. The unadjusted VTE rate was 0.39% and ranged between 0% - 2.65%. The overall VTE/Bleeding composite score was 2.15 and ranged between 1.15 - 3.19. This measure seeks to provide clinician groups with a tool to assess their patient bleeding and VTE rates and compare them to their peers, ultimately providing an evidence-based quality metric assessing orthopedic practices.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Denominator Exclusion Criteria
See this image and copyright information in PMC

References

    1. CMS. Medicare Program, Federal Register. 2016. November 15, 2016.
    1. CMS. Comprehensive Care for Joint Replacement Model. CMS.gov.
    1. Rosemont, IL, USA: Fifth AJRR Annual Report on Hip and Knee Arthroplasty Data. Amer. Joint Replacement Registry. Annu. Rep. 2018.
    1. Inacio MCS, Paxton EW, Graves SE, Namba RS, Nemes S. Projected increase in total knee arthroplasty in the United States – an alternative projection model. Osteoarthritis and Cartilage. 2017;25(11):1797–803. - PubMed
    1. Singh JA, Yu S, Chen L, Cleveland JD. Rates of Total Joint Replacement in the United States: Future Projections to 2020–2040 Using the National Inpatient Sample. The Journal of Rheumatology. 2019;46(9):1134–40. - PubMed

LinkOut - more resources